Browse Biological products industry topic

Political activity subtopic

Articles 1-12 out of 12 article(s) Title Author Type Date Words Chief Medical Officer of BioTime's Subsidiary OncoCyte Corporation to Deliver Keynote Address at Fifth Chinese Congress on Stem Cell Therapy in Beijing, P.R. China. Oct 22, 2009 495 BioTime CEO Dr. Michael West to Present at World Stem Cells & Regenerative Medicine Congress 2009 and Discuss New Cell Lines with Cartilage-Forming Potential. May 7, 2009 498 Biogen Idec Features Data on AVONEX(R) and TYSABRI(R) and Showcases the Company's Multiple Sclerosis Development Pipeline at the World Congress On Treatment and Research in Multiple Sclerosis. Sep 18, 2008 1850 Titan Pharmaceuticals Announces Spheramine(R) Presentations at 12th International Congress of Parkinson's Disease and Movement Disorders. Jun 24, 2008 1160 BioTime CEO Dr. Michael West Presents at European Stem Cells & Regenerative Medicine Congress 2008. May 15, 2008 484 Genocea Biosciences Wins "Best Vaccine Startup" Award at World Vaccine Congress 2008. Apr 23, 2008 355 Multicenter PolyHeme Trauma Study Presented at the American College of Surgeons 93rd Annual Clinical Congress. Clinical report Oct 10, 2007 1877 ATryn(R) Introduced at International Society on Thrombosis and Haemostasis Congress. Jul 9, 2007 1079 Array BioPharma to Present Clinical Data at the European League Against Rheumatism (EULAR) Annual Meeting and the 8th World Congress on Inflammation. May 30, 2007 1147 New Congressional Defense Bill Supports Development and Purchase of Vaccines to Meet the Nation's Public Health Threats; AVANT Expects to Participate in the Development of New Vaccine Technologies to Meet These Threats. Dec 22, 2005 738 AVI BIOPHARMA INITIATES PHASE II CARDIOVASCULAR CLINICAL STUDY. Nov 1, 2005 687 Targeted Genetics Presents Additional Data from Its Inflammatory Arthritis Program at the 13th Annual Congress of the European Society of Gene Therapy. Oct 31, 2005 1556